Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effectiveness of ADT with or without Darolutamide in Men with Newly Diagnosed Metastatic Prostate Cancer and Limited Functional Ability

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium France Germany Ireland Italy The Netherlands +4
  • BMS-986365 in Metastatic Castration-Sensitive Prostate Cancer in Patients with Suboptimal PSA Response After ADT and ARPI

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    Germany
  • Comparing Copper (64Cu) Chloride PET/CT and Fluorocholine (18F) PET/CT for Detecting Metastasis in Prostate Cancer Patients at Risk

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    Italy
  • Study on Using Copper (64Cu) Chloride PET/CT Imaging for Prostate Cancer Patients with Biochemical Relapse After Surgery to Guide Radiation Therapy

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    Italy
  • A Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy

    Not recruiting

    3 1 1
    Belgium Bulgaria Czechia Finland France Germany +6
  • Study of JSB462 and lutetium (177Lu) vipivotide tetraxetan combination for adult men with PSMA-positive metastatic castration resistant prostate cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Austria Czechia France Germany Italy The Netherlands +1
  • Study of Fuzuloparib, Abiraterone Acetate, and Prednisone for First-Line Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1
    Belgium Czechia France Hungary Poland Spain
  • Study of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate

    Not recruiting

    3 1 1 1
    Czechia France Germany Greece Hungary Italy +5
  • Study of Debio 4228 for Patients with Advanced or Metastatic Prostate Cancer

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium Bulgaria France Italy Lithuania Poland +1
  • Study on Radium-223, Docetaxel, and Prednisone for Patients with Bone-Only Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    2 1 1 1
    Italy